Literature DB >> 19614717

Validity of ascertainment of co-morbid illness using administrative databases: a systematic review.

J R Leal1, K B Laupland.   

Abstract

Co-morbid illnesses have a major influence on the epidemiology of infectious diseases. Although International Classification of Diseases (ICD) discharge codes are frequently used to evaluate the presence of co-morbidities in observational research, additional research is required about their validity. We reviewed the evidence supporting the use of routinely coded administrative data for ascertainment of co-morbid diseases with emphasis as it relates to the study of infectious diseases. A systematic Medline, Embase, and bibliographic review were conducted in order to identify and critically appraise published (1990-2008) studies comparing administrative databases with conventional chart review. Twenty-one co-morbidities commonly associated with infectious diseases risk were a priori selected for specific evaluation. Of the 21 co-morbid conditions chosen, only 19 had adequate data available for evaluation. Thirteen studies were included; only one focused on an infectious disease population. Eleven articles validated individual co-morbid conditions data in electronic administrative databases and reported a wide range of pooled sensitivity (13-82%) but overall high pooled specificity (>97%) when compared with medical chart review. Seven articles compared Charlson Co-morbidity Index scores derived from administrative data algorithms as compared with that calculated from medical record review and found that administrative data underscored the index in all articles with kappa agreement ranging from 0.30 to 0.56. The small body of literature published to date suggests that electronic administrative databases have limited validity for co-morbidity evaluation. Studies evaluating administrative database ascertainment of co-morbidities specifically in infectious diseases research are needed.

Entities:  

Mesh:

Year:  2009        PMID: 19614717     DOI: 10.1111/j.1469-0691.2009.02867.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  22 in total

1.  Swine exposure and methicillin-resistant Staphylococcus aureus infection among hospitalized patients with skin and soft tissue infections in Illinois: A ZIP code-level analysis.

Authors:  Glennon A Beresin; J Michael Wright; Glenn E Rice; Jyotsna S Jagai
Journal:  Environ Res       Date:  2017-07-31       Impact factor: 6.498

Review 2.  [The validity of routine data on quality assurance: A qualitative systematic review].

Authors:  E Hanisch; T F Weigel; A Buia; H-P Bruch
Journal:  Chirurg       Date:  2016-01       Impact factor: 0.955

3.  The Effect of Adding Comorbidities to Current Centers for Disease Control and Prevention Central-Line-Associated Bloodstream Infection Risk-Adjustment Methodology.

Authors:  Sarah S Jackson; Surbhi Leekha; Laurence S Magder; Lisa Pineles; Deverick J Anderson; William E Trick; Keith F Woeltje; Keith S Kaye; Kristen Stafford; Kerri Thom; Timothy J Lowe; Anthony D Harris
Journal:  Infect Control Hosp Epidemiol       Date:  2017-07-03       Impact factor: 3.254

Review 4.  A Systematic Review of Comorbidity Measurement Methods for Patients With Nontraumatic Brain Injury in Inpatient Rehabilitation Settings.

Authors:  Wayne Khuu; Vincy Chan; Angela Colantonio
Journal:  Am J Phys Med Rehabil       Date:  2017-11       Impact factor: 2.159

5.  Electronically Available Comorbid Conditions for Risk Prediction of Healthcare-Associated Clostridium difficile Infection.

Authors:  Anthony D Harris; Alyssa N Sbarra; Surbhi Leekha; Sarah S Jackson; J Kristie Johnson; Lisa Pineles; Kerri A Thom
Journal:  Infect Control Hosp Epidemiol       Date:  2018-02-05       Impact factor: 3.254

6.  Association of β-Blockers With Functional Outcomes, Death, and Rehospitalization in Older Nursing Home Residents After Acute Myocardial Infarction.

Authors:  Michael A Steinman; Andrew R Zullo; Yoojin Lee; Lori A Daiello; W John Boscardin; David D Dore; Siqi Gan; Kathy Fung; Sei J Lee; Kiya D R Komaiko; Vincent Mor
Journal:  JAMA Intern Med       Date:  2017-02-01       Impact factor: 21.873

7.  Prevalence and impact of non-cardiovascular comorbidities among older adults hospitalized for non-ST segment elevation acute coronary syndrome.

Authors:  Richard Ofori-Asenso; Ella Zomer; Ken Lee Chin; Peter Markey; Si Si; Zanfina Ademi; Andrea J Curtis; Sophia Zoungas; Danny Liew
Journal:  Cardiovasc Diagn Ther       Date:  2019-06

8.  Electronically Available Comorbidities Should Be Used in Surgical Site Infection Risk Adjustment.

Authors:  Sarah S Jackson; Surbhi Leekha; Laurence S Magder; Lisa Pineles; Deverick J Anderson; William E Trick; Keith F Woeltje; Keith S Kaye; Timothy J Lowe; Anthony D Harris
Journal:  Clin Infect Dis       Date:  2017-09-01       Impact factor: 9.079

9.  Exploring the application of the Charlson Comorbidity Index to assess the patient population seen in a Veterans Affairs chiropractic residency program.

Authors:  Vivian T Ly; Brian C Coleman; Christopher M Coulis; Anthony J Lisi
Journal:  J Chiropr Educ       Date:  2021-10-01

10.  The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients.

Authors:  Sandra K Thygesen; Christian F Christiansen; Steffen Christensen; Timothy L Lash; Henrik T Sørensen
Journal:  BMC Med Res Methodol       Date:  2011-05-28       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.